|
|
Defining the Role of DNA Rereplication of Chromosome 21 in the Development and Pathophysiology of Down Syndrome |
| 1 R01 AI155918-01 |
BLACK, JOSHUA CRANSTON |
NIAID |
2021 |
|
|
The Impact of Maternal CMV Infection on Birth Outcomes |
| 1 R03 AI151426-01A1 |
STOWE, RAYMOND PRESTON |
NIAID |
2021 |
|
|
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome |
| 1 R21 AI161827-01 |
LENZ, LAUREL L |
NIAID |
2021 |
|
|
Project 3 - Mechanisms of DNRAb-mediated damage to the fetal brain |
| 5 P01 AI073693-12 |
DIAMOND, BETTY |
NIAID |
2021 |
|
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
| 5 R01 AI141662-03 |
YEAGER, MICHAEL E |
NIAID |
2021 |
|
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
| 5 R01 AI143710-03 |
WU, PINGSHENG |
NIAID |
2021 |
|
|
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome |
| 5 R01 AI145988-03 |
SULLIVAN, KELLY D |
NIAID |
2021 |
|
|
Mediator kinases as interferon antagonists in Down Syndrome |
| 5 R01 AI156739-02 |
TAATJES, DYLAN J |
NIAID |
2021 |
|
|
Molecular Neuro-pathogenesis of Congenital Cytomegalovirus Infection |
| 5 SC1 AI112785-08 |
TANG, QIYI |
NIAID |
2021 |
